Back

Early impairment of endothelial and myocardial function in patients with hidradenitis suppurativa

31 August 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Autoimmune and chronic inflammatory disorders and heart disease (2) Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Konstantinos Katogiannis

Attikon University Hospital, Athens (Greece)

8 More presentations in this session

Presentation thumbnail
Chronic inflammation is associated with impaired cardiac structure and function in patients with inflammatory arthritis: the ARTCADIA Study
Doctor M. Sengelov (Hellerup, DK)
Abstract Slides Video
Presentation thumbnail
Advanced biologic therapies are associated with fewer adverse cardiovascular events in patients with inflammatory bowel diseases
Doctor T. Harb (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
Vascular thrombosis and relapse-associated factors in Behcet's syndrome: a comprehensive analysis of 136 patients
Doctor S. Chadli (Rabat, MA)
Abstract Slides Video
Presentation thumbnail
The potential effects of methotrexate on cardiovascular outcomes in rheumatoid arthritis patients: a multi-institutional analysis
Doctor M. Cervantes (Dallas, US)
Abstract Slides Video
Presentation thumbnail
Association of inflammation with left ventricular mass index in patients with rheumatoid arthritis
Doctor A. Linde (Oslo, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Autoimmune and chronic inflammatory disorders and heart disease (2)

The Event

Event poster

ESC Congress 2024

31 August 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac structure and function is associated with systemic inflammation in psoriasis and palmoplantar pustulosis: the PSOCADIA study
thumbnail
Congress Presentation
Cardiac manifestations of psoriasis and palmoplantar pustulosis: the PSOCADIA study
thumbnail
Congress Presentation
Comparing indices of systemic inflammation and cardiac phenotype between hypertensive and non-hypertensive hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources